Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 4 days agoViking Therapeutics soared after its weight-loss drug topped Zepbound's Phase 3 results. Recently,...
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 14 hours agoEli Lilly has a full lineup of medicine that should drive revenue growth for a long time, including...
Biogen stock rises on sales of groundbreaking Alzheimer's drug
Quartz· 5 days agoBiogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge,...
Eli Lilly buys injectable medicine manufacturing facility in Wisconsin (NYSE:LLY)
Seeking Alpha· 7 days agoEli Lilly acquires manufacturing facility from Nexus Pharmaceuticals, expanding its global...
Biogen Beats Estimates as Alzheimer’s Drug Gains Traction
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Biogen Inc. reported first-quarter profit that beat Wall Street’s expectations as the...
Eisai hunts for next Alzheimer’s drug with new research pact
BioPharma Dive via Yahoo Finance· 7 days agoThe cash influx helped BioArctic turn a profit. Leqembi could face new competition soon. Eli Lilly’s...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoA key asset in Lilly’s pipeline is donanemab for early Alzheimer’s disease, which is under review...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 4 days agoIndustry: Big Pharma Link: https://www.zacks.com/commentary/2260758/4-large-drug...
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
Motley Fool via Yahoo Finance· 2 days agoIn March, Wegovy was granted an expanded indication by the Food and Drug Administration (FDA) to...
Forget Nvidia, These Unstoppable Stocks Are Better Buys
Motley Fool via Yahoo Finance· 2 days agoOn top of this, there's also Eli Lilly's early Alzheimer's treatment, donanemab, which may obtain...